Friday, October, 23, 2009
Treating Schizophrenia
October 03, 2008
The U.S. Food and Drug Administration has agreed to review a new
medication to treat bipolar disorder and schizophrenia. The med,
asenapine, is a fast-dissolving tablet designed to treat
schizophrenia and acute mania or mixed episodes in people with
bipolar I disorder.
Read more »
Expert & Community Posts
By Jerry Kennard
,
Health Expert
...or Nrg-1, forms the basis for the development of schizophrenia. The Nrg-1 protein is essential...
Read more »
By Paul Ballas
,
Health Expert
Recently, I was reviewing the literature on tardive dyskinesia, and it struck me how frustrating it...
Read more »
By Jerry Kennard
,
Health Expert
...research indicates that a broad-brush approach to treating schizophrenia is unlikely to be of...
Read more »
By Robin Cunningham
,
Health Expert
...concerning the initial success of researchers in treating schizophrenia using compounds that...
Read more »
Health Guide
...incidence in relatives of schizophrenics. Schizotypal personality disorder should not be confused with
schizophrenia. People with schizotypal personality disorder tend to have odd beliefs and...
Read more »
...repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in
schizophrenia: a meta-analysis. J Clin Psychiatry. 2007 Mar;68(3):416-21.Crespo-Facorro B,...
Read more »
Schizophrenia is categorized as a brain disease, not a psychological disorder, and drug treatment is the primary therapy. Studies indicate, however, that an integrated approach better...
Read more »
CausesNo single cause can account for
schizophrenia. Rather, it appears to be the result of multiple causes such as genetic factors, environmental and psychological assaults, and possible hormonal...
Read more »
...Studies indicate that clozapine (Clozaril) and quetiapine (Seroquel), antipsychotic drugs used to treat
schizophrenia, may be the best drugs for treating psychosis in patients with Parkinson...
Read more »
Related News
November 27, 2008
(Ivanhoe Newswire) -- A panel of government and health-industry experts has developed a list of 14 widely prescribed medications they say urgently...
Read summary »
October 02, 2008
Solvay Pharmaceuticals and Wyeth Pharmaceuticals have submitted an application to the U.S. Food and Drug Administration for approval of bifeprunox, a...
Read summary »
July 30, 2009
Phase III clinical trials on a new drug to treat schizophrenia have been stopped, its makers report. Officials with drugmakers Lundbeck and Solvay...
Read summary »
October 02, 2008
The Food and Drug Administration (FDA) has approved extended-release Invega for the treatment of schizophrenia. The FDA made the decision after...
Read summary »
October 02, 2008
This is a study to evaluate the safety and effectiveness of a new drug, SB-773812, in adults with acute schizophrenia. The drug's effects will also...
Read summary »